|
HS Code |
114979 |
| Iupac Name | 4-chloro-6-methyl-2-(trifluoromethyl)quinoline |
| Molecular Formula | C11H7ClF3N |
| Molecular Weight | 247.63 g/mol |
| Appearance | Pale yellow to off-white powder |
| Cas Number | 1072959-82-2 |
| Melting Point | 63-67°C |
| Solubility | Slightly soluble in organic solvents |
| Smiles | CC1=CC2=C(C=CC(=N2)C(F)(F)F)C(=C1)Cl |
| Inchi | InChI=1S/C11H7ClF3N/c1-6-3-8-7(4-9(6)12)5-16-10(8)11(13,14)15/h3-5H,1-2H3 |
| Pubchem Cid | 44452510 |
As an accredited 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle labeled "4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline, 25g" with hazard symbols and batch number, securely sealed. |
| Shipping | 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline should be shipped in tightly sealed containers, protected from moisture and light. Handle with care and comply with relevant hazardous goods regulations. Ensure proper labeling (including CAS number 91713-46-5) and include safety documentation. Recommended shipping temperature is ambient unless specified otherwise by the supplier’s safety guidelines. |
| Storage | 4-Chloro-6-methyl-2-(trifluoromethyl)quinoline should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from direct sunlight and sources of heat or ignition. Keep it separated from incompatible substances such as strong oxidizers and acids. Proper chemical labeling and secondary containment are recommended to prevent accidental exposure or environmental contamination. |
Applications of 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline in Industrial ManufacturingAs a specialized manufacturer, we supply 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline for technically demanding sectors that require consistent purity and reliable sourcing. The compound is widely used as a high-value intermediate in regulated downstream industries, supporting advanced synthesis protocols and strict quality control expectations. Below are the core industrial applications verified from real downstream integration. 1. Pharmaceutical Intermediate for Antimalarial Drug SynthesisThis compound serves as a critical building block in the advanced synthesis of active pharmaceutical ingredients (APIs) for next-generation antimalarial medications, specifically as an intermediate in producing substituted quinoline derivatives. Pharmaceutical manufacturers introduce it during multi-step organic synthesis sequences, favoring its stability and fluorinated profile to drive specific substitutions that would otherwise be challenging. Using this intermediate enables efficient construction of therapeutic backbones with improved pharmacokinetics and metabolic stability, which are required by stricter global regulatory review. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate for Modern Herbicide FormulationsLeading agrochemical producers use this compound as a selective precursor when manufacturing certain novel quinoline-based herbicides. Its electron-withdrawing trifluoromethyl group enables key transformations in late-stage functionalization by nucleophilic aromatic substitution and directed cross-coupling reactions. Integrating it carefully into the synthesis pathway provides active ingredient frameworks with high selectivity, allowing formulators to lower active ingredient dosages while maintaining weed control efficacy. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Synthesis of Specialty Fluorinated MaterialsProducers of specialty polymers and advanced electronic materials exploit the unique electronic effects of this quinoline in their development of functionalized, fluorinated monomers and additives. The compound participates in regioselective substitutions that lead to building blocks for high-performance materials such as fluorinated resins and charge-transport layers. Its use in these specialty syntheses allows downstream manufacturers to modulate dielectric properties and thermal stability for critical electronic, aerospace, and photonics applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Key Intermediate in Veterinary Drug SynthesisManufacturers in the veterinary pharmaceutical industry employ this molecule as a derivatization intermediate for preparing active substances targeting animal-specific parasitic infections. Its structural scaffold allows efficient attachment of substituents that improve bioavailability in target species. Controlled integration during synthesis ensures consistency in final profile and meets veterinary regulation on residue limits and safety. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline in our facility requires more than a standard approach. Each batch demands hands-on involvement from our experienced technicians, careful temperature control, and strict attention to detail. Our teams use carefully purified starting materials, and we invest heavily in refining our proprietary synthesis routes. For years, our focus has been to reduce impurities and avoid the kind of byproduct accumulation that can disrupt subsequent reactions in user processes.
4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline owes its increasing popularity in pharmaceutical and agrochemical R&D to its unique structure. The presence of both a trifluoromethyl group and a chlorine on the quinoline core opens up a variety of downstream opportunities for chemists. The interplay of these functional groups gives rise to a molecule with both electron-withdrawing properties and selective reactivity, which is hard to match with simpler analogues.
We rely on an optimized multi-step synthesis, developed and improved in-house through years of small and large-scale production experience. Early on, we faced the challenge of controlling regioselectivity during the trifluoromethylation step, which could easily lead to contamination by closely related quinoline isomers. Decades of incremental process improvement led us to a reliable route, and our teams regularly monitor every batch by high-performance liquid chromatography and nuclear magnetic resonance spectroscopy. Each drum ships only after our internal QC team verifies every specification. Consistency matters—both to our teams and our global clients.
We decided to standardize production of 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline at a purity that routinely exceeds 98%. This decision didn’t come lightly. Lower-purity options would cut costs, but our clients complained of unmanageable side products in downstream couplings and condensations. By targeting a higher threshold, we make sure our product supports high-yield transformations in both pilot projects and full-scale campaigns.
Our experience shows that researchers gravitate toward this quinoline derivative for applications where precise halogen and trifluoromethyl substitutions are essential. In medicinal chemistry, its backbone often forms the core of antimalarial scaffolds, kinase inhibitors, and other lead compounds where minor changes to substitution pattern can mean the difference between activity and inactivity. Some agrochemical innovators draw upon this backbone for its balance of lipophilicity and metabolic stability, aiming for new classes of crop protection molecules.
We started producing small research quantities, but as the molecule’s impact became clearer, scale-up requests followed. Clients asked for larger lots because once they succeeded in lab-scale optimizations, scale consistency between batches became mission-critical for late-stage development. Our years of feedback taught us which specification limits matter most—water content below 0.2%, residual solvents checked batch-by-batch, minimal heavy metal contamination. We learned that reliable logistics are as important as pure product, so we put extra focus on inventory tracking and prompt shipment.
Our lab teams have spent years optimizing every parameter, from reaction times and solvent choices to work-up and drying procedures. We protect our process knowledge jealously because it took real world learning—and costly missteps—to get where we are today. Some producers cut corners at the cost of higher residual moisture, unwanted regioisomers, or uncontrolled traces of starting materials. These shortcuts end up burdening the downstream chemist with hours of extra purification, lower yields, or unexpected biological results. By sticking to our specification, we help research teams stay confident that their valuable time translates to progress, not troubleshooting.
Unlike some competitive materials that contain inconsistent crystalline forms, our 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline maintains a stable morphology and clear color profile. We’ve learned how to avoid solvent inclusions—an issue that once caused batch variation and shipped product visibly different from one order to the next. Feedback from our clients keeps informing our process, and direct communication makes it possible for our technical team to troubleshoot rare customer issues in real time.
Every lot ships with a complete analytical worksheet and traceable production records. Some clients are surprised by the level of transparency we offer, but we have found that up-front documentation saves headaches during regulatory filings. Our facility registration and audit history form part of our reputation; we undergo periodic reviews from both internal and external auditors specializing in fine chemicals for regulated markets.
We’ve seen the real impact of minor unchecked contaminants. In one partnership, an external analysis revealed problematic halogenated byproducts from an earlier supplier. That disruption caused project delays and required revalidation of synthetic paths. Our response was to put in even tighter in-process controls, which have since caught minor contaminant drift before reaching the final purification stage. Years of producing for demanding pharmaceutical partners have made us acutely aware that the cost of error multiplies further down the research stream. Mistakes hidden in early steps compound once scale-up begins.
Our own warehouse team stores product under cool, dry conditions, keeping the compound away from possible cross-contamination and moisture absorption. Early batches taught us that unchecked exposure to atmospheric humidity could alter both the weight and appearance of the product—an issue that caused confusion about yield and mass balance on the customer’s end. We invested in new packaging: every drum has a hermetic liner and a tamper-evident seal so every chemist opening a new container can trust its contents.
When shipping internationally, we stick by every regulatory detail, including applicable shipping and customs documentation. Problems with delayed shipments and missing safety data once cost us a long-standing partner, so now our logistics teams confirm every shipping condition ahead of dispatch. By keeping direct involvement from order to delivery, our customers rarely see surprises in either product consistency or shipment status.
The landscape of quinoline derivatives includes many halogen- or alkyl-substituted analogues, but the combined effect of chlorine and trifluoromethyl at positions 4 and 2 gives this molecule a particular edge. Compared with the simpler 2-chlorinated or methyl-substituted quinolines, our product takes advantage of fluorine’s unique contribution to lipophilicity, electron distribution, and metabolic resilience in the resulting molecules. Research teams often tell us that selective reactions at other positions—like nucleophilic aromatic substitution or oxidative coupling—go more predictably when using our molecule as a starting point. This points to less batch-to-batch variability and more predictable results for their end applications.
Some experimentalists compare our product with similar tetrafluorinated or dichlorinated quinolines, noting that those lack the same balance of activation and stability. Our own process optimization led us away from over-halogenation after seeing reduced yields and increased unwanted side product formation in both the lab and pilot plant. Every functional group brings both benefits and trade-offs; in our hands, 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline consistently lands at the sweet spot for further synthetic modification and final product performance.
Supporting skilled chemists means knowing not just how to produce a compound, but also how it fits into real synthetic workflows. Early on, some users shared their difficulties with solubility and extraction—feedback we actively used to refine post-reaction purification and drying processes. Each step, from final filtration to packaging, reflects those cumulative lessons from daily practice. We believe this practical feedback loop makes the difference between a commodity supplier and a true industry partner.
One overlooked detail in many commercial quinolines is trace color variation, which signals small but significant impurity levels. Years ago, early clients flagged this as a marker for downstream reactivity—minuscule changes sometimes resulted in reversed selectivity during Suzuki or Buchwald couplings. By adopting new analytical techniques and setting narrower color acceptance limits, we managed to cut uncertainty and make scale-up more straightforward for downstream process chemists.
Chemists using 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline look for more than just a molecular tool. Many of our industry partners check the reliability of our shipments across multiple projects, expecting consistent supply and robust analysis with each reorder. Over years of production, we got plenty of direct calls from labs and process development teams needing technical backup. These conversations often point out small but important tweaks—perhaps a tighter moisture limit or a desire for more granular impurity data from batch to batch. Because we collect and apply this feedback in real time, every batch reflects a few more lessons learned the hard way.
Direct partnerships with both pharmaceutical and academic groups have pushed us to build a traceable history of on-time delivery and open troubleshooting. The process wasn’t always smooth, and we missed the mark at times, but every problem emphasized that ongoing, open dialog makes for better product and fewer headaches on both sides.
Consistent chemical supply means paying as much attention to environmental and ethical responsibilities as to the chemistry. By investing in waste reduction during synthesis and treating all effluents on-site, we prevent harmful byproducts from leaving our facility. Lessons from earlier missteps—like excessive solvent use or incomplete recycling—drove us to adopt greener technologies wherever possible. For instance, improved solvent recovery meant we could lower total waste output and—at the same time—reduce costs passed on to end users. We’re not perfect yet, but years spent in production taught us that sustainability only works when it’s built into the normal workflow, not tacked on at the end.
We understand that production of specialty halogenated molecules draws attention—both from regulatory bodies and local communities. Routine third-party audits and investment in robust emission controls form a large part of our operating budget. At each stage, we commit to keeping all personnel informed and equipped, reducing both workplace risk and environmental footprint.
Making complex, halogen-rich intermediates like 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline means accepting a certain amount of risk—including fire safety, exposure controls, and rigorous worker training. Early on, we realized that lack of upfront investment in equipment and regular staff retraining led to close calls and unexpected stoppages. Now, we keep strict protocols for all hazardous reagents, maintain redundant safety systems, and routinely drill emergency procedures. Direct, consistent oversight not only reduces on-site accident rates, but also ensures product batches are protected from unintended cross-contamination.
Many of our partners care about these safety standards. Our longstanding policy keeps visitors and inspectors free to walk the production line, check training logs, and observe bottle-to-drum transfer details up close. This openness may slow down tours or add prep time, but nothing replaces the long-term confidence it builds with our partners and downstream users.
From chemicals designed for early discovery work to those intended for highly regulated end-uses, all batches of 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline meet tight, well-documented standards for residual solvents, water content, and byproduct levels. Our teams work side-by-side with both regulatory specialists and line operators to interpret—and sometimes anticipate—the changing demands from end-use industries.
Some international clients face changing customs requirements or shifting health authority guidelines when importing specialty fine chemicals. We have faced direct requests for additional analytical documentation, specialized packaging formats, or supplemental impurity breakdowns. Each request, even if it slows down order processing, reflects the real-world needs of our partners and underlines the importance of flexibility and readiness to adapt.
The original synthetic route for this molecule came from close collaboration between our in-house research chemists and the production operators running kilo-scale reactors. Chemistry on bench scale rarely matches its behavior in a multi-hundred-liter vessel; solvent ratios, heat transfer, and reagent charging all change under scale-up. We learned quickly that even minor changes—such as agitation speed or order of addition—could mean the difference between a smooth run and an expensive stoppage. The result of years spent refining this process is a reproducible, high-purity product our clients can rely on every time. We keep our innovation cycle open by running periodic pilot trials and testing tweaks under real plant conditions before making full-scale process changes.
Open lines of communication between R&D and our plant teams let us respond nimbly to both scientific advances and customer challenges—whether this means fine-tuning process parameters or providing additional sample lots for critical testing.
One theme from our customer base stands out: the downstream success of a project often hinges on the reliability of each intermediate. If the intermediate contains unanticipated trace contaminants or fails to match its analytical specification, final yields suffer or batch failures increase—costing both time and money. Several downstream colleagues shared that earlier problems in final drug candidate production traced directly to undetected impurities in a quinoline intermediate, costing entire campaigns weeks or months to resolve.
By taking charge of every detail—from material selection to final shipment—we own the full production chain. That way, our manufacturing partners spend less effort double-checking each intermediate, knowing we understand the same pressures they face. After decades in the field, we've seen that even seemingly minor specification drift can have outsize impact on high-value synthetic efforts.
We view every shipment as an opportunity to reinforce trust. If an issue arises, our team welcomes critical feedback and follows up directly until the client feels satisfied with the resolution. Technical support isn’t farmed out—we answer calls and emails with hands-on insight gained from our production experience. That responsiveness allows for practical, tailored advice, whether you're troubleshooting an unexpected crystal form during isolation or debating a reactivity issue in scale-up.
In our field, incremental progress means everything. Adjustments to synthesis and purification build up over time, with each customer request bringing potential for process improvements, specification tightening, or expanded analytical services. This culture of ongoing responsiveness has shaped everything about our delivery—from product performance to documentation to shipment speed.
Choosing where to source a compound as specialized as 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline often means weighing technical support, supply reliability, and analytical depth, not simply price and availability. Traders and resellers offer marketplace scale but can’t match the hands-on experience we provide as the producer. Over time, the value from a reliable direct partnership grows—the technical lessons shared, the mutual trust built, and the confidence embedded into every batch.
Our team stands behind every kilogram produced, drawing from countless production runs, on-call technical support, and genuine investment in customer success. We welcome direct communication, on-site visits, and both positive and constructive feedback to keep setting new benchmarks for quality and reliability.
Real value in the fine chemicals world stems not from a single innovation or specification, but from the combination of technical rigor, transparent communication, and a relentless drive for improvement. After years of producing and refining 4-Chloro-6-Methyl-2-(Trifluoromethyl)Quinoline, we’ve come to see our role as part of every client’s research and development effort. Consistency, openness, and learning from both successes and setbacks keep our process sharp and our partners equipped for success—one synthesis at a time.